1. Juckenhöfel S, Feisel C, Schmitt HJ, Biedler A. TIVA with propofol-remifentanil or balanced anesthesia with sevoflurane-fentanyl in laparoscopic operations. Hemodynamics, awakening and adverse effects. Anaesthesist. 1999; 48:807–12.
Article
2. Kiriyama S, Naitoh H, Kuwano H. Propofolsedationduringendoscopictreatmentforearlygastriccancercomparedtomidazolam. World J Gastroenterol. 2014; 20:11985–90.
Article
3. Zhang Y, Shan GJ, Zhang YX, Cao SJ, Zhu SN, Li HJ, First Study of Perioperative Organ Protection (SPOP1) investigators, et al. Propofolcomparedwithsevofluranegeneralanaesthesiaisassociatedwithdecreaseddelayedneurocognitiverecoveryinolderadults. Br J Anaesth. 2018; 121:595–604.
Article
4. Sahinovic MM, Struys MMRF, Absalom AR. Clinical pharmacokinetics and pharmacodynamics of propofol. Clin Pharmacokinet. 2018; 57:1539–58.
Article
5. Hemphill S, McMenamin L, Bellamy MC, Hopkins PM. Propofol infusion syndrome: a structured literature review and analysis of published case reports. Br J Anaesth. 2019; 122:448–59.
Article
6. Wesolowski AM, Zaccagnino MP, Malapero RJ, Kaye AD, Urman RD. Remimazolam: Pharmacologic Considerations and Clinical Role in Anesthesiology. Pharmacotherapy. 2016; 36:1021–7.
Article
7. Tuk B, Van Oostenbruggen MF van, Herben VM, Mandema JW, Danhof M. Characterization of the pharmacodynamic interaction between parent drug and active metabolite in vivo: midazolam and alpha-OH-midazolam. J Pharmacol Exp Ther. 1999; 289:1067–74.
8. Cornett EM, Novitch MB, Brunk AJ, Davidson KS, Menard BL, Urman RD, et al. New benzodiazepines for sedation. Best Pract Res Clin Anaesthesiol. 2018; 32:149–64.
Article
9. Noor N, Legendre R, Cloutet A, Chitneni A, Varrassi G, Kaye AD. A comprehensive review of remimazolam for sedation. Heal Psychol Res. 2021; 9:1–11.
Article
10. Kim KM. Remimazolam: pharmacological characteristics and clinical applications in anesthesiology. Anesth Pain Med. 2022; 17:1–11.
Article
11. Schüttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers Part I. Pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020; 132:636–51.
12. Liu T, Lai T, Chen J, Lu Y, He F, Chen Y, et al. Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery: A randomized, double-blind, controlled trial. Pharmacol Res Perspect. 2021; 9:e00851.
Article
13. Shi F, Chen Y, Li H, Zhang Y, Zhao T. Efficacy and Safety of Remimazolam Tosilate versus Propofol for General Anesthesia in Cirrhotic Patients Undergoing Endoscopic Variceal Ligation. Int J Gen Med. 2022; 15:583–91.
Article
14. Dai G, Pei L, Duan F, Liao M, Zhang Y, Zhu M, et al. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia. Minerva Anestesiol. 2021; 87:1073–9.
Article
15. Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020; 34:543–53.
Article
16. Zhang X, Li S, Liu J. Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial. BMC Anesthesiol. 2021; 21:156.
Article
17. Pastis NJ, Yarmus LB, Schippers F, Ostroff R, Chen A, Akulian J, et al. Safety and Efficacy of Remimazolam Compared With Placebo and Midazolam for Moderate Sedation During Bronchoscopy. Chest. 2019; 155:137–46.
Article
18. Mashour GA, Kent C, Picton P, Ramachandran SK, Tremper KK, Turner CR, et al. Assessment of intraoperative awareness with explicit recall: A comparison of 2 METHODS. Anesth Analg. 2013; 116:889–91.
19. Chiang MH, Wu SC, Hsu SW, Chin JC. Bispectral Index and non-Bispectral Index anesthetic protocols on postoperative recovery outcomes. Minerva Anestesiol. 2018; 84:216–28.
Article
20. Punjasawadwong Y, Phongchiewboon A, Bunchungmongkol N. Bispectral Index for Improving Anaesthetic Delivery and Postoperative Recovery, Cochrane Database of Systematic Reviews. Cochrane Database Syst Rev. 2014; 17:CD003843.
21. Kazuhiro S, Keiko N, Shota T, Kazuya I, Kosuke N, Shinnosuke T, et al. Neurological sedative indicators during general anesthesia with remimazolam. J Anesth. 2022; 36:194–200.
Article
22. Oh J, Park SY, Lee SY, Song JY, Lee GY, Park JH, et al. Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups. Korean J Anesthesiol. 2022; 75:510–7.
Article